Global Plasmid DNA Manufacturing Market Overview 2024: Size, Growth Rate, and Segments
The plasmid dna
manufacturing global market report 2024from The Business Research Company
provides comprehensive market statistics, including global market size,
regional shares, competitor market share, detailed segments, trends, and
opportunities. This report offers an in-depth analysis of current and future
industry scenarios, delivering a complete perspective for thriving in the
industrial automation software market.
Plasmid DNA Manufacturing Market, 2024report by The Business Research Company
offers comprehensive insights into the current state of the market and highlights
future growth opportunities.
Market Size - The plasmid DNA manufacturing market size has grown
exponentially in recent years. It will grow from $1.89 billion in 2023 to $2.34
billion in 2024 at a compound annual growth rate (CAGR) of 23.6%. The growth in
the historic period can be attributed to the application of plasmid DNA in
industrial processes, the use of plasmid DNA in creating genetically modified
organisms, the production of monoclonal antibodies using plasmid DNA in cell
lines, international health initiatives, plasmid DNA is used in bioremediation
and other environmental applications and microbiome studies.
The plasmid DNA manufacturing market size is expected to see exponential growth
in the next few years. It will grow to $5.49 billion in 2028 at a compound
annual growth rate (CAGR) of 23.7%. The growth in the forecast period can be
attributed to the increasing use of plasmid DNA in the development of DNA
vaccines for infectious diseases, increasing adoption of plasmid DNA in the
development of antibody-drug conjugates, personalized therapies, the use of
plasmid DNA in developing cancer treatments and intellectual property
developments. Major trends in the forecast period include increased activity in
licensing agreements for plasmid DNA technologies, customized solutions, cost
reduction strategies, high-throughput screening, and the development of
scalable manufacturing solutions.
Order your report now for swift delivery @ https://www.thebusinessresearchcompany.com/report/plasmid-dna-manufacturing-global-market-report
Scope Of Plasmid DNA Manufacturing Market
The Business Research
Company's reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market's historical
performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market
landscape.
4. Key Segments: Breakdown of the market into its primary segments and their
respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and
geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting
the market.
Plasmid DNA Manufacturing Market Overview
Market Drivers -The growing acceptance of gene therapy is expected to propel
the growth of the plasmid DNA manufacturing market going forward. Gene therapy
refers to a medical treatment that involves modifying or manipulating a
person's genes to treat or prevent disease. Gene therapy is on the rise due to
advancements in genetic engineering technologies, increased investment in
research and development, successful clinical trials, and the growing
prevalence of genetic disorders, which together highlight its potential for
providing long-term or permanent cures. Plasmid DNA manufacturing is essential
for gene therapy as it produces the vectors needed to deliver therapeutic genes
into cells, facilitating the treatment of genetic disorders. For instance,
according to the American Society of Gene & Cell Therapy, a US-based
non-profit medical and scientific organization, the number of gene therapies in
Phase III clinical trials grew by 10% in Q3 2023, the first quarterly increase
since Q3 2022. Therefore, the growing acceptance of gene therapy is driving the
growth of the plasmid DNA manufacturing market.
Market Trends - Major companies operating in the plasmid DNA manufacturing
market are developing advanced bioprocessing technologies to enhance the
efficiency, scalability, and quality of plasmid DNA production. These
innovations aim to streamline the manufacturing process, reduce production
costs, and ensure that the plasmid DNA meets stringent regulatory standards for
therapeutic applications. For instance, in January 2023, Charles River
Laboratories, a US-based pharmaceutical company, launched eXpDNA platform,
designed for the efficient production and purification of high-quality plasmid
DNA. This platform integrates advanced bioprocessing technologies, scalable
production methods, and rigorous quality control measures to produce plasmid
DNA that meets the stringent requirements for therapeutic and clinical
applications. The eXpDNA platform is used extensively in gene therapy, DNA
vaccine development, and other biopharmaceutical applications that demand high
yield, purity, and consistency.
The plasmid DNA manufacturing market covered in this report is segmented –
1) By Grade: Research And Development Grade, Good Manufacturing Practice (GMP)
Grade
2) By Development Phase: Pre-Clinical Therapeutics, Clinical Therapeutics,
Marketed Therapeutics
3) By Disease: Infectious Disease, Cancer, Genetic Disorder, Other Diseases
4) By Application: Deoxyribonucleic Acid (DNA) Vaccines, Cell And Gene Therapy,
Immunotherapy, Other Applications
Get an inside scoop of the plasmid dna manufacturing market, Request now for
Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15895&type=smp
Regional Insights - North America was the largest region in the plasmid DNA
manufacturing market in 2023. Asia-Pacific is expected to be the
fastest-growing region in the forecast period. The regions covered in the
plasmid DNA manufacturing market report are Asia-Pacific, Western Europe, Eastern
Europe, North America, South America, Middle East, Africa.
Key Companies - Major companies operating in the plasmid DNA manufacturing
market are Thermo Fisher Scientific Inc., Eurofins Genomics LLC, Catalent Inc.,
Charles River Laboratories, Recipharm AB, Kaneka Corp., Genscript Biotech
Corporation, Aldevron LLC, Genewiz, OriGene Technologies, Celonic AG, Creative
Biogene, Cellectis, Synbio Technologies, VectorBuilder Inc., Altogen
Biosystems, Addgene, Andelyn Biosciences, AGC Biologics, VGXI, BioCat GmbH,
GeneCopoeia, PlasmidFactory GmbH & Co. KG, Akron Biotech, PackGene Biotech
lnc.
Table of Contents
1. Executive Summary
2. Plasmid DNA
Manufacturing Market Characteristics
3. Plasmid DNA
Manufacturing Market Trends And Strategies
4. Plasmid DNA
Manufacturing Market - Macro Economic Scenario
5. Global Plasmid DNA
Manufacturing Market Size and Growth
.....
32. Global Plasmid DNA
Manufacturing Market Competitive Benchmarking
33. Global Plasmid DNA
Manufacturing Market Competitive Dashboard
34. Key Mergers And
Acquisitions In The Plasmid DNA Manufacturing Market
35. Plasmid DNA
Manufacturing Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Comments
Post a Comment